The present situation and progress of 125I particle implantation therapy guided by multimodality imaging for malignant tumors
10.3969/J.ISSN.1672-8270.2017.04.004
- VernacularTitle:多模态影像引导125I粒子植入治疗恶性肿瘤的现状与进展
- Author:
Xiaodong LI
;
Rongfu WANG
- Keywords:
Radioactive 125I particle;
Implantation therapy;
Brachytherapy;
Multimodal imaging guidance;
Optimization of radiation dosage;
Therapeutic gain ratio
- From:
China Medical Equipment
2017;14(4):21-24
- CountryChina
- Language:Chinese
-
Abstract:
How to study a method that can significantly improve the therapeutic gain ratio of malignant tumor is one of the problems must be solved in the field of cancer therapy. However, how can effectively treat malignancy patients with contraindications of operation, radiotherapy and chemotherapy has been a difficult problem in cancer therapy. The 125I brachytherapy was suitable for malignancy patients with contraindications of operation, radiotherapy and chemotherapy. The guidance of multimodal imaging could contribute to the definitions of tissue density imaging target and biological target, and could ensure the targeting and conformity of treatment. Using the quality assurance and quality control measurements (QA/QC) optimized by radiation dosimetry; using therapy planning system (TPS) to make plan, and adopt optimizing radiation dosimetry and dose volume histogram (DVH) to evaluate TPS, and using image to guide particle implantation and adopt series of methods, such as real-time location verification, dosimetry verification post-implantation, therapy efficacy determination, follow-up and so on, to improve therapeutic gain ratio and partially control therapy efficacy, and then significantly reduce adverse reaction. All of these have important clinical value for increasing survival rate and quality of life.
